Eric Secemsky MD MSc(@EricSecemskyMD) 's Twitter Profileg
Eric Secemsky MD MSc

@EricSecemskyMD

Interventional Cardiologist/Director of Vascular Intervention | Outcomes Researcher | Associate Prof of Med | Proud Father and Husband | Opinions my own

ID:899796419900559361

calendar_today22-08-2017 00:52:38

4,8K Tweets

4,4K Followers

1,3K Following

Follow People
The VIVA Foundation(@VIVAPhysicians) 's Twitter Profile Photo

Attention U.S. physicians in training: Scholarships are available for & !

Receive full travel funding (airfare and up to 5 nights hotel) by registering by August 7

Learn more and register: viva-foundation.org/physicians-in-…

Attention U.S. physicians in training: Scholarships are available for #VIVA24 & #TheVEINS24! Receive full travel funding (airfare and up to 5 nights hotel) by registering by August 7 Learn more and register: viva-foundation.org/physicians-in-…
account_circle
Eli Gelfand, MD, FACC(@the_gelf) 's Twitter Profile Photo

A clinical consensus statement on ANOCA from the BIDMC Cardiovascular Division, put together by
Prihatha Narasimmaraj, MD, mentored by Connie Tsao, MD, MPH and Eric A Osborn MD PhD - the result of a fantastic discussion at our regular Clinical Consensus Conference at BIDMC CVI BIDMC CV Fellowship

A clinical consensus statement on ANOCA from the BIDMC Cardiovascular Division, put together by @prihatha, mentored by @ConnieTsaoMD and @ericalanosborn - the result of a fantastic discussion at our regular Clinical Consensus Conference at @BidmcCvi @BIDMCVFellows
account_circle
Tai Kobayashi(@TaiKobayashiMD) 's Twitter Profile Photo

Late Breaker Dr. Tai Kobayashi speaks with Dr. Alraies at SCAI Scientifi... youtu.be/H33qRl7Lr-8?si… via YouTube

Thanks to my co-investigators and my mentors Jay Giri and Eric Secemsky MD MSc. Congratulations to endovascular engineering for a successful First in Human study!

account_circle
MyJSCAI(@MyJSCAI) 's Twitter Profile Photo

💥Featured Clinical Research at :

💡First in Human Safety & Feasibility of a Novel Catheter Thrombectomy Device for the Treatment of (The ENGULF Trial)

Read the abstract & article:
doi.org/10.1016/j.jsca…

Tai Kobayashi

💥Featured #LateBreaker Clinical Research at #SCAI2024: 💡First in Human Safety & Feasibility of a Novel Catheter Thrombectomy Device for the Treatment of #PulmonaryEmbolism (The ENGULF Trial) Read the abstract & article: doi.org/10.1016/j.jsca… @TaiKobayashiMD
account_circle
Jay Giri(@jaygirimd) 's Twitter Profile Photo

Tai Kobayashi presents & publishes ENGULF trial: first in human experience with novel E2 Helo Catheter at SCAI Now 2024.

15F catheter w/ 24F expandable tip, dual articulations for navigation, & an internal agitator.

Good safety and RV improvement.

jscai.org/article/S2772-…

@TaiKobayashiMD presents & publishes ENGULF trial: first in human experience with novel E2 Helo Catheter at @SCAI 2024. 15F catheter w/ 24F expandable tip, dual articulations for navigation, & an internal agitator. Good safety and RV improvement. jscai.org/article/S2772-…
account_circle
MyJSCAI(@MyJSCAI) 's Twitter Profile Photo

📢Simultaneous Publication at !

💡In this multicenter, first-in-human study, use of the Hēlo Thrombectomy Catheter was feasible & safe for the treatment of acute PE.

Tai Kobayashi

Read more now:
➡️doi.org/10.1016/j.jsca…

Ido Weinberg, MD

📢Simultaneous Publication at #SCAI2024! 💡In this multicenter, first-in-human study, use of the Hēlo #PE Thrombectomy Catheter was feasible & safe for the treatment of acute PE. @TaiKobayashiMD Read more now: ➡️doi.org/10.1016/j.jsca… @Angiologist
account_circle
MyJSCAI(@MyJSCAI) 's Twitter Profile Photo

🗣️Featured Clinical Research at - 'Temporal Trends & Clinical Outcomes w vs Arterial Access for in the US' in 💡Presented by Reza Fazel, MD, FSCAI

➡️bit.ly/4aYBMhY

🗣️Featured Clinical Research #LateBreaker at #SCAI2024 - 'Temporal Trends & Clinical Outcomes w #Radial vs #Femoral Arterial Access for #PCI in the US' in #JSCAI 💡Presented by Reza Fazel, MD, FSCAI ➡️bit.ly/4aYBMhY
account_circle
The VIVA Foundation(@VIVAPhysicians) 's Twitter Profile Photo

Highlights

-CLTI, Aortic, Dialysis, & PharmacoRx Pre-courses
-NEW PE Summit covering the basics of PE, tech & trials, & complex cases
-Hands-on Cadaver Lab
-Live Case Demonstrations
-RN/Tech program

Agenda: viva-foundation.org/agenda24

Register now: viva-foundation.org/register

#VIVA24 Highlights -CLTI, Aortic, Dialysis, & PharmacoRx Pre-courses -NEW PE Summit covering the basics of PE, tech & trials, & complex cases -Hands-on Cadaver Lab -Live Case Demonstrations -RN/Tech program Agenda: viva-foundation.org/agenda24 Register now: viva-foundation.org/register
account_circle
SCAI Now(@SCAI) 's Twitter Profile Photo

Last but not least,Joseph Kim shares insights on How Global Events Influence Treatment Equality and Outcomes Following Femoropopliteal Revascularization. 🌎

Last but not least,@JMKimMD shares insights on How Global Events Influence Treatment Equality and Outcomes Following Femoropopliteal Revascularization. 🌎 #SCAI2024 #PAD
account_circle
SCAI Now(@SCAI) 's Twitter Profile Photo

Next, Eric Secemsky MD MSc shares the conclusion from his study 'The Dynamic Landscape of Femoropopliteal Revascularization Practices Amidst Controversy and Pandemic' here at . 🗣️

Next, @EricSecemskyMD shares the conclusion from his study 'The Dynamic Landscape of Femoropopliteal Revascularization Practices Amidst Controversy and Pandemic' here at #SCAI2024. 🗣️ #PAD
account_circle